BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2158210)

  • 1. Neurokinin A enhances the stimulatory effects of d-amphetamine on motor activity in the nucleus accumbens of the rat.
    Van den Bos R; Cools AR; Ogren SO
    Acta Physiol Scand; 1990 Mar; 138(3):423-4. PubMed ID: 2158210
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurokinin A enhances the stimulatory effects of d-amphetamine on motor activity in the nucleus accumbens of the rat.
    Van den Bos R; Cools AR; Ogren SO
    Acta Physiol Scand; 1989 Dec; 137(4):547-8. PubMed ID: 2557730
    [No Abstract]   [Full Text] [Related]  

  • 3. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
    Vaccarino FJ; Rankin J
    Behav Neurosci; 1989 Aug; 103(4):831-6. PubMed ID: 2765186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the mesencephalic locomotor region with locomotor activity induced by injections of amphetamine into the nucleus accumbens.
    Brudzyński SM; Mogenson GJ
    Brain Res; 1985 May; 334(1):77-84. PubMed ID: 2986781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of amphetamine and apomorphine on locomotor activity after kainic acid lesion of the nucleus accumbens septi in the rat.
    Kafetzopoulos E
    Psychopharmacology (Berl); 1986; 88(3):271-4. PubMed ID: 3083447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Septal lesions enhance hyperactivity induced either by amphetamine or lesions of the nucleus accumbens septi.
    Carey RJ
    Behav Brain Res; 1982 May; 5(1):43-52. PubMed ID: 7082466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of dopamine agonists with disrupted mesolimbic pathways implications for mental health.
    Wray SR; Melville GN; Wenger T; Louden D
    West Indian Med J; 1984 Jun; 33(2):106-16. PubMed ID: 6541399
    [No Abstract]   [Full Text] [Related]  

  • 8. Intra-nucleus accumbens amphetamine: dose-dependent effects on food intake.
    Evans KR; Vaccarino FJ
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1149-51. PubMed ID: 3809216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine facilitates the in vivo release of neurokinin A in the nucleus accumbens of the rat.
    Lindefors N; Brodin E; Ungerstedt U
    Eur J Pharmacol; 1989 Feb; 160(3):417-20. PubMed ID: 2540996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi.
    Kelly PH; Roberts DC
    Pharmacol Biochem Behav; 1983 Jul; 19(1):137-43. PubMed ID: 6413984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced place preference in rats with 5,7-dihydroxytryptamine lesions of the nucleus accumbens.
    Spyraki C; Nomikos GG; Galanopoulou P; Daïfotis Z
    Behav Brain Res; 1988 Jul; 29(1-2):127-34. PubMed ID: 2840924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleus accumbens lesions reduce amphetamine hyperthermia but not hyperactivity.
    Wirtshafter D; Asin KE; Kent EW
    Eur J Pharmacol; 1978 Oct; 51(4):449-52. PubMed ID: 710513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic potentiation of neuroleptic effects in the nucleus accumbens.
    Vance MA; Blumberg JB
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):345-8. PubMed ID: 6136070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors?
    Costall B; Fortune DH; Hui SC; Naylor RJ
    Eur J Pharmacol; 1980 May; 63(4):347-58. PubMed ID: 6104603
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of oxaprotiline enantiomers given repeatedly on the behavioural effects of d-amphetamine and dopamine injected into the nucleus accumbens.
    Maj J; Wedzony K
    Eur J Pharmacol; 1988 Jan; 145(2):97-103. PubMed ID: 3350045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus.
    Solomon PR; Staton DM
    Biol Psychiatry; 1982 Jun; 17(6):743-56. PubMed ID: 7104422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a novel environment on locomotor hyperactivity of rats induced by apomorphine in the nucleus accumbens.
    Morgenstern R; Fink H
    Biomed Biochim Acta; 1985; 44(10):1517-22. PubMed ID: 4084255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite effects of D-amphetamine on spontaneous neuronal activity in the neostriatum and nucleus accumbens.
    Rebec GV; Zimmerman KS
    Brain Res; 1980 Nov; 201(2):485-91. PubMed ID: 7191347
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholecystokinin potentiation of dopamine-mediated behaviors in the nucleus accumbens.
    Crawley JN
    Ann N Y Acad Sci; 1985; 448():283-92. PubMed ID: 3861122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.